General Court provides guidance on assessing bad faith in ENTEROSGEL case
In invalidity proceedings between Health Product Group and Bioline Pharmaceutical AG, the General Court confirmed that the predecessor in law to Bioline had not acted in bad faith when designating the European Union in respect of the international registration for ENTEROSGEL.
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10